KCNMA1 and cancer: Indeed, analyzing OC tissues derived from a small cohort of patients, it was revealed that the levels of KCNMA1 mRNA were significantly reduced in drug resistant compared to sensitive cancers, which was consistent with the hypothesis that inhibition of KCa1.1 channels can lead to alterations in cisplatin sensitivity in OC patients [33].